Kim Shontz

1.4k total citations
11 papers, 445 citations indexed

About

Kim Shontz is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cell Biology. According to data from OpenAlex, Kim Shontz has authored 11 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 4 papers in Cell Biology. Recurrent topics in Kim Shontz's work include Muscle Physiology and Disorders (10 papers), Cardiomyopathy and Myosin Studies (5 papers) and Virus-based gene therapy research (3 papers). Kim Shontz is often cited by papers focused on Muscle Physiology and Disorders (10 papers), Cardiomyopathy and Myosin Studies (5 papers) and Virus-based gene therapy research (3 papers). Kim Shontz collaborates with scholars based in United States and Italy. Kim Shontz's co-authors include Jerry R. Mendell, Zarife Sahenk, Louise R. Rodino‐Klapac, K. Reed Clark, Linda Lowes, Brian K. Kaspar, Samiah Al-Zaidy, Sarah Lewis, Lindsay N. Alfano and Mark Hogan and has published in prestigious journals such as Neurology, American Journal of Physiology-Cell Physiology and Molecular Therapy.

In The Last Decade

Kim Shontz

11 papers receiving 440 citations

Peers

Countries citing papers authored by Kim Shontz

Since Specialization

Citations

This map shows the geographic impact of Kim Shontz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim Shontz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim Shontz more than expected).

Fields of papers citing papers by Kim Shontz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim Shontz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim Shontz. The network helps show where Kim Shontz may publish in the future.

Co-authorship network of co-authors of Kim Shontz

This figure shows the co-authorship network connecting the top 25 collaborators of Kim Shontz. A scholar is included among the top collaborators of Kim Shontz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim Shontz. Kim Shontz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

#	Work	Indexed citations
1	Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes 2017 ·Molecular Therapy ·Jerry R. Mendell, Zarife Sahenk, Samiah Al-Zaidy, Louise R. Rodino‐Klapac, Linda Lowes, Lindsay N. Alfano, Katherine Berry, N. Miller, Mehmet E. Yalvaç, Igor Dvorchik, Melissa Moore‐Clingenpeel, Kevin M. Flanigan, Kathleen Church, Kim Shontz, (unknown), Sarah Lewis, Markus McColly, Mark Hogan, Brian K. Kaspar	80
2	Safety and Efficacy of AAV Retrograde Pancreatic Ductal Gene Delivery in Normal and Pancreatic Cancer Mice 2017 ·Molecular Therapy — Methods & Clinical Development ·(unknown), Jason J. Kwon, (unknown), (unknown), Constance J. Temm, Max Jacobsen, George E. Sandusky, Kim Shontz, Louis G. Chicoine, K. Reed Clark, Joshua T. Mendell, Murray Korc, Janaiah Kota	20
3	Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for Duchenne Muscular Dystrophy (DMD): Clinical Update and Longitudinal Comparison to External Controls on Six-Minute Walk Test (6MWT) (S28.001) 2016 ·Neurology ·Jerry R. Mendell, Nathalie Goemans, Louise R. Rodino‐Klapac, Zarife Sahenk, Linda Lowes, Lindsay N. Alfano, Katherine Berry, (unknown), Sarah Lewis, Kim Shontz, James Shao, Petra W. Duda, (unknown), Frédéric Schnell, (unknown), Bruce M. Wentworth, Edward M. Kaye, Eugenio Mercuri, (unknown)	1
4	Eteplirsen, a phosphorodiamidate morpholino oligomer (PMO) for Duchenne muscular dystrophy (DMD): Longitudinal comparison to external controls on six-minute walk test (6MWT) and loss of ambulation (LOA) 2016 ·Neuromuscular Disorders ·J. Mendell, (unknown), Louise R. Rodino‐Klapac, Zarife Sahenk, Linda Lowes, Lindsay N. Alfano, Katherine Berry, (unknown), Sarah Lewis, Kim Shontz, James Shao, Petra W. Duda, Eugenio Mercuri	2
5	AAV.Dysferlin Overlap Vectors Restore Function in Dysferlinopathy Animal Models 2015 ·Annals of Clinical and Translational Neurology ·(unknown), Danielle A. Griffin, Eric R. Pozsgai, R.W. Johnson, William E. Grose, Kristin N. Heller, Kim Shontz, Chrystal L. Montgomery, (unknown), K. Reed Clark, Zarife Sahenk, Jerry R. Mendell, Louise R. Rodino‐Klapac	76
6	C-2. Eteplirsen, a Phosphorodiamidate Morpholino Oligomer (PMO) for the Treatment of Duchenne Muscular Dystrophy (DMD): 168 Week Update on Six-Minute Walk Test (6MWT), Pulmonary Function Testing (PFT), and Safety 2015 ·Molecular Therapy ·Jerry R. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, (unknown), (unknown), Linda Lowes, Lindsay N. Alfano, Katherine Berry, Sarah Lewis, Kim Shontz, Kevin M. Flanigan, Christopher Shilling, Petra W. Duda, Jay Saoud	1
7	A Phase 1/2a Follistatin Gene Therapy Trial for Becker Muscular Dystrophy 2014 ·Molecular Therapy ·Jerry R. Mendell, Zarife Sahenk, Vinod Malik, Ana M. Gómez, Kevin M. Flanigan, Linda Lowes, Lindsay N. Alfano, Katherine Berry, Eric S. Meadows, Sarah Lewis, Lyndsey Braun, Kim Shontz, (unknown), K. Reed Clark, Xiomara Q. Rosales, Samiah Al-Zaidy, Alessandra Govoni, Louise R. Rodino‐Klapac, Mark Hogan, Brian K. Kaspar	189
8	Human α7 Integrin Gene (ITGΑ7) Delivered By Adeno-Associated Virus Reverses The Phenotype Of The Double Knock Out (DKO) Mouse Devoid Of Dystrophin And Utrophin (P5.099) 2014 ·Neurology ·Kristin N. Heller, Chrystal L. Montgomery, Kim Shontz, Paul M.L. Janssen, (unknown), Jerry R. Mendell, Louise R. Rodino‐Klapac	1
9	Results at 96 Weeks of a Phase IIb Extension Study of the Exon-Skipping Drug Eteplirsen in Patients with Duchenne Muscular Dystrophy (DMD) (S6.002) 2014 ·Neurology ·Edward M. Kaye, Jerry R. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda Lowes, Lindsay N. Alfano, (unknown), Sarah Lewis, Vinod Malik, Kim Shontz, Christopher Shilling, Peter Sazani, Jihad B. Saoud	1
10	P.11.20 Results at 2 years of a phase IIb extension study of the exon-skipping drug eteplirsen in patients with DMD 2013 ·Neuromuscular Disorders ·J. Mendell, Louise R. Rodino‐Klapac, Zarife Sahenk, Kandice Roush, Loren Bird, Linda Lowes, Lindsay N. Alfano, (unknown), Sarah Lewis, (unknown), Kim Shontz, (unknown), John R. Kean, Hugh D. Allen, Christopher Shilling, Peter Sazani, Jihad B. Saoud, Edward M. Kaye	1
11	Overexpression of Galgt2 in skeletal muscle prevents injury resulting from eccentric contractions in both mdx and wild-type mice 2008 ·American Journal of Physiology-Cell Physiology ·Paul T. Martin, Rui Xu, Louise R. Rodino‐Klapac, (unknown), Marybeth Camboni, Chrystal L. Montgomery, Kim Shontz, Louis G. Chicoine, K. Reed Clark, Zarife Sahenk, Jerry R. Mendell, Paul M.L. Janssen	73

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact